Clinical Study
Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
Table 1
Demographical and clinical characteristics of patients with Graves’ disease and Hashimoto’s thyroiditis.
| | | Graves’ disease ( = 198) | Hashimoto's thyroiditis ( = 77) |
| | Gender—male/female (%) | 18/180 (9.09/90.91) | 5/72 (6.49/93.51) | | Age—yrs (range) | 45.5 (13–84) | 51 (15–84) | | Age at diagnosis—yrs (range) | 36.5 (9–81) | 48 (5–77) | | Disease duration—yrs (range) | 9.08 (0.5–27) | 3 (0.1–21) | | Total thyroid volume—cc (range) | 55.7 (1.6–242) | 15.8 (1–111.9) | | Nodules present (%) | 55 (27.78) | 39 (50.65) | | PTC (%) | 10 (5.05) | 6 (7.79) | | Time of followup—yrs (range) | 5 (0.1–20) | 7 (0.1–21) | | Smoking (%)a | 67 (50.38) | 14 (41.18) | | Time of treatment—yrs (range) | 5.5 (0.1–20) | 6.6 (1–16) | | Ophthalmopathy (%)b | 27 (19.71) | NA | | Active disease (%) | 176 (88.89) | NA | | Radioiodine treatment (%) | 66 (33.33) | NA |
|
|
a = 133 for GD and = 34 for HT.
b = 137.
NA: not available.
|
